Consistent with this notion, rare RB1-proficient SCLC tumors exhibit relatively lower neuroendocrine marker expression and are enriched for YAP1, implying that YAP1-driven tumors may arise in cases where RB1 loss is incomplete or functionally compensated [38]. The gene discussed is RB1; the disease is small cell lung carcinoma.